Article Details

Transparency: exceptional measures for COVID-19 medicines

Retrieved on: 2025-06-30 21:00:59

Tags for this article:

Click the tags to see associated articles and topics

Transparency: exceptional measures for COVID-19 medicines. View article details on hiswai:

Excerpt

EMA is making data from the marketing authorisation applications for COVID-19 mRNA vaccines Comirnaty and Spikevax publicly available. It includes ...

Article found on: www.ema.europa.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo